Bath & Body Works (NYSE:BBWI) Receives Outperform Rating from Telsey Advisory Group

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reissued by equities research analysts at Telsey Advisory Group in a note issued to investors on Thursday,Benzinga reports. They presently have a $38.00 price target on the stock. Telsey Advisory Group’s target price would indicate a potential upside of 138.50% from the stock’s previous close.

BBWI has been the topic of a number of other reports. Morgan Stanley increased their price objective on shares of Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Citigroup lowered their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a report on Tuesday, August 19th. Jefferies Financial Group lowered their price objective on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating for the company in a research report on Monday, October 13th. Barclays reduced their target price on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Monday, October 20th. Finally, Wells Fargo & Company lowered their price target on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, October 27th. Ten equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $38.18.

Bath & Body Works Trading Down 24.3%

Shares of BBWI traded down $5.11 during trading hours on Thursday, reaching $15.93. The company had a trading volume of 12,595,127 shares, compared to its average volume of 5,595,404. Bath & Body Works has a 12-month low of $15.63 and a 12-month high of $41.87. The firm has a 50 day simple moving average of $25.07 and a 200-day simple moving average of $28.34. The company has a market capitalization of $3.29 billion, a price-to-earnings ratio of 4.74, a PEG ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Sell-side analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current year.

Institutional Trading of Bath & Body Works

A number of hedge funds have recently made changes to their positions in BBWI. Parkside Financial Bank & Trust grew its holdings in Bath & Body Works by 24.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after purchasing an additional 364 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares during the last quarter. Gabelli Funds LLC boosted its stake in shares of Bath & Body Works by 1.2% during the 3rd quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock valued at $1,225,000 after buying an additional 542 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Bath & Body Works by 3.7% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after buying an additional 600 shares in the last quarter. Finally, Natixis Advisors LLC increased its stake in shares of Bath & Body Works by 0.7% in the first quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock worth $2,732,000 after buying an additional 629 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.